Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/2014
09/17/2014EP2776065A1 Combination therapies using anti- pseudomonas psl and pcrv binding molecules
09/17/2014EP2776064A1 Provasopressin antagonists and uses thereof
09/17/2014EP2776063A1 Influenza virus -like particles (vlps) comprising hemagglutinin produced nicotiana tabacum
09/17/2014EP2776062A1 Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use
09/17/2014EP2776061A1 Multispecific and multivalent binding proteins and uses thereof
09/17/2014EP2776060A1 Vaccine for tumor immunotherapy
09/17/2014EP2776054A2 Antagonists for abnormal vasopressin v2 receptor and uses thereof
09/17/2014EP2776051A1 Therapeutic combinations and methods of treating melanoma
09/17/2014EP2776042A2 Combination drug therapy for the treatment of solid tumors
09/17/2014EP2776032A2 Treatment of hematologic malignancies with an anti-cxcr4 antibody
09/17/2014EP2776022A1 New treatment for neurodegenerative diseases
09/17/2014EP2775986A1 Film packaging for oral biologics
09/16/2014USRE45137 Adjuvanted meningococcus compositions
09/16/2014US8835712 Transgenic trasnchromosomal rodents for making human antibodies
09/16/2014US8835620 Vaccines against multiple subtypes of dengue virus
09/16/2014US8835619 Heat shock proteins from Mycobacterium leprae and uses thereof
09/16/2014US8835613 β-mannosylceramide and stimulation of NKT cell anti-tumor immunity
09/16/2014US8835611 Calicheamicin derivative-carrier conjugates
09/16/2014US8835610 IL-17 binding proteins
09/16/2014US8835609 Antigen binding sites to non-functional oligomeric P2X7 receptors and methods of use thereof
09/16/2014US8835608 Anti-MRP3 antibodies and methods of use
09/16/2014US8835606 Anti-cancer antibodies with reduced complement fixation
09/16/2014US8835603 Agents for the treatment of celiac disease
09/16/2014US8835133 Humanized anti-beta7 antagonists and uses therefor
09/16/2014US8835123 Methods for detecting progenitor cells and uses thereof
09/16/2014US8835119 Lectin pathway deficiency assay
09/16/2014US8835111 Genotyping tool for improving the prognostic and clinical management of MS patients
09/16/2014US8835107 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics
09/16/2014US8834899 Photodynamic therapy-generated mesothelioma vaccine
09/16/2014US8834898 Cholera toxin chimera and its use as a staph vaccine
09/16/2014US8834897 Methods for using tetanus toxin for beneficial purposes in animals (mammals)
09/16/2014US8834896 Vault compositions for immunization
09/16/2014US8834895 Use of Francisella tularensis for prevention and treatment of allergic airway disorders
09/16/2014US8834894 Compositions and methods for vaccinating against HSV-2
09/16/2014US8834893 Nucleic acid derived from hepatitis C virus and expression vector, transformed cell, and hepatitis C virus particles each prepared by using the same
09/16/2014US8834892 Method of preparing live viral vaccines by genetic engineering of viral genome
09/16/2014US8834891 Immunogenic compositions comprising Lawsonia intracellularis
09/16/2014US8834890 Siderophore conjugate immunogenic compositions and vaccines
09/16/2014US8834889 Antigen presenting composition and use thereof
09/16/2014US8834888 Adjuvanting meningococcal factor H binding protein
09/16/2014US8834887 Drug for suppressing pathogen occurring in vivo
09/16/2014US8834886 Camptothecin-binding moiety conjugates
09/16/2014US8834885 Methods for identification of sites for IgG conjugation
09/16/2014US8834884 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
09/16/2014US8834883 Anti-VEGF antibodies and uses thereof
09/16/2014US8834882 Antibodies to CD70
09/16/2014US8834881 Human binding molecules capable of binding to and neutralizing influenza B viruses and uses thereof
09/16/2014US8834880 Antibodies directed to angiopoietin-2 and uses thereof
09/16/2014US8834879 Methods of treating fibroproliferative disorders of the kidney or reducing kidney fibrosis
09/16/2014US8834878 Antigen-antibody cancer recognition system
09/16/2014US8834876 Therapeutic agent for hematopoietic tumors
09/16/2014US8834875 Notch1 binding agents and methods of use thereof
09/16/2014US8834874 Methods and compositions for increasing iduronate 2-sulfatase activity in the CNS
09/16/2014US8834873 Method for detecting and controlling cancer
09/16/2014US8834872 Uses of antibodies
09/16/2014US8834871 Immunoglobulin molecules with improved characteristics
09/16/2014US8834870 Treatment of leukemias and chronic myeloproliferative diseases with antibodies to EphA3
09/16/2014US8834853 Coated dehydrated microorganisms with enhanced stability and viability
09/16/2014CA2727830C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment and management of multiple myeloma
09/16/2014CA2689726C Antibodies against gpi.alpha.
09/16/2014CA2631714C Nanoparticles for use in immunogenic compositions
09/16/2014CA2631556C Functional epitopes of streptococcus pneumoniae psaa antigen and uses thereof
09/16/2014CA2545806C Methods of modulating immunity
09/16/2014CA2529798C Methods of treating hepatocellular carcinoma with zvegf3 antagonists
09/16/2014CA2526240C 7a5/prognostin and use thereof for the diagnostic and therapy of tumors
09/16/2014CA2512729C Identification and engineering of antibodies with variant fc regions and methods of using same
09/16/2014CA2510309C Recombinant vaccine viruses expressing il-15 and methods of using the same
09/16/2014CA2504532C Botulinum neurotoxin b receptors and use thereof
09/16/2014CA2492556C Hsp70 from arthrobacter
09/16/2014CA2484420C Antibodies specific for human cd22 and their therapeutic and diagnostic uses
09/15/2014CA2809714A1 Infectious genomic dna clone and serological profile of torque teno sus virus 1 and 2
09/12/2014WO2014138748A1 Transcutaneous dosage formulation
09/12/2014WO2014138696A1 Immunotherapeutic potential of modified lipooligosaccharides/lipid a
09/12/2014WO2014138449A1 Anti-c-met tandem fc bispecific antibodies
09/12/2014WO2014138315A1 Heparanase expression in human t lymphocytes
09/12/2014WO2014138290A1 Compositions and methods for treating bacterial infections
09/12/2014WO2014138188A1 Human ctla4 mutants and use thereof
09/12/2014WO2014138183A1 Specific detection tool for mesenchymal and epithelial-mesenchymal transformed circulating tumor cells
09/12/2014WO2014137962A1 Antibodies that bind il-23
09/12/2014WO2014137961A1 Anti-tnf-anti-il-17 bispecific antibodies
09/12/2014WO2014137249A2 Method for producing a vaccine against foot-and-mouth disease
09/12/2014WO2014137248A1 Method for producing antirabies vaccine
09/12/2014WO2014136910A1 ANTIBODY TO PEPTIDE ENCODED BY Exon-21 OF PERIOSTIN, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF INFLAMMATORY DISEASE CONTAINING SAID ANTIBODY
09/12/2014WO2014135803A1 Use of attenuated parasite strains for the prevention and/or treatment of eye wounds associated with an infection by toxoplasma gondii
09/12/2014WO2014135694A1 Treatment and prevention of remote ischemia-reperfusion injury
09/12/2014WO2014135651A1 Acellular pertussis vaccine
09/12/2014WO2014135611A1 Combination therapy for neoplasia treatment
09/12/2014WO2014134698A1 Cpg oligonucleotide formulations and methods and uses thereof
09/12/2014WO2013109995A9 Fused antigen vaccines and compositions against streptococcus pneumoniae
09/11/2014US20140256795 Co-activation of mtor and stat3 pathways to promote neuronal survival and regeneration
09/11/2014US20140256652 Polypeptides Involved In Immune Response
09/11/2014US20140255449 Dosage of dnak
09/11/2014US20140255448 Vaccine composition and immunization method
09/11/2014US20140255447 Production of avian embryo cells
09/11/2014US20140255446 Acellular pertussis vaccine
09/11/2014US20140255445 Synthetic viruses and uses thereof
09/11/2014US20140255444 Compositions and methods for treating ebola virus infection
09/11/2014US20140255439 Virus-like particles and process for preparing same
09/11/2014US20140255437 Topk peptides and vaccines including the same
09/11/2014US20140255436 Immunogenic compositions useful in provoking an integrated response to tumor antigens
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 1823